News

Sebastian Nijman presenting at BioTrinity 2021

Rene van den oever

Scenic Biotech and Genentech expand their Genetic Modifier Partnership

Phillipe dro (1)

Scenic Biotech Appoints Dr. Philippe Dro as Independent Chairman

Ton Schumacher, member of Scenic’s Scientific Advisory Board has been awarded the Jeantet-Collen Prize for Translational Medicine

1. scenic biotech genetic modifier image 1

Scenic’s Chief Scientific Officer Sebastian Nijman explains why genetic modifiers are an untapped source of drug targets

Scenic Biotech Enters into Genetic Modifier Collaboration with Genentech

2. c5w4ahaxeaawkds

Scenic founders publish paper in Science Signaling

Izeboud oscar 1200

Scenic Biotech Appoints Oscar Izeboud as Chief Executive Officer

Rene van den oever

Scenic Biotech Awarded €3.1 million Innovation Credit from Dutch Government to Progress CD47/QPCTL Immuno-oncology Program

Amsterdam thijn brummelkamp van scenic biotech.

Interview with Scenic’s founder Thijn Brummelkamp in Labiotech

Scenic’s platform technology patent receives notice of allowance

Scenic’s advisor Ton Schumacher identifies a modifier of the CD47 “don’t eat me” checkpoint